SOLTI1710 PROMETEO II: Palbociclib in combination with letrozole in hormone receptor-positive (HR+)/HER2-negative residual disease after standard neoadjuvant chemotherapy (NAC)
No Thumbnail Available
Identifiers
Date
2021-05-08
Authors
Ciruelos, E.
Salvador Bofill, F. J.
Perello Martorell, A.
Alba Conejo, E.
Gonzalez-Farre, X.
Palacios-Ozores, P.
Merino, M.
Villagrasa, P.
Vila Navarro, E.
Pascual, T.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
